Author:
Molina-Pena Rodolfo,Ferreira Natalia Helen,Roy Charlotte,Roncali Loris,Najberg Mathie,Avril Sylvie,Zarour Mariana,Bourgeois William,Ferreiros Alba,Lucchi Chiara,Cavalieri Francesco,Hindre François,Tosi Giovani,Biagini Giuseppe,Valzania Franco,Berger François,Abal Miguel,Russeau Audrey,Boury Frank,Alvarez-Lourenzo Carmen,Garcion Emmanuel
Reference101 articles.
1. ) ; (ii) the "R�gion Pays-de-la-Loire" under the frame of the Target'In project (Improvement of targeting radiopharmaceuticals for better diagnostic and therapy;LabEx IRON (Innovative Radiopharmaceuticals in Oncology and Neurology) as part of the French government Investissements d'Avenir program
2. (CD49) under the frame of the FusTarG project (Design and application of precision RNA oligonucleotides and aptamers for targeting gene fusion products in glioblastoma to E.G.) and iv) the "Tumour targeting, Imaging and radiotherapies network" of the;Minist�re de l'Enseignement sup�rieur, de la recherche et de l'innovation
3. Recurrent Glioblastoma: From Molecular Landscape to New Treatment Perspectives;C Birzu;Cancers,2021
4. Morphological and flow cytometric analysis of cell infiltration in glioblastoma: a comparison of autopsy brain and neuroimaging;T Yamahara;Brain Tumor Pathol,2010
5. Cost of migration: invasion of malignant gliomas and implications for treatment;A Giese;J Clin Oncol,2003